tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT

Sarepta Therapeutics (SRPT) Stock News & Sentiment

2,777 Followers
Sarepta price target lowered to $175 from $177 at JPMorgan
PremiumThe Fly
Sarepta price target lowered to $175 from $177 at JPMorgan
7d ago
Sarepta price target raised to $173 from $167 at UBS
PremiumThe Fly
Sarepta price target raised to $173 from $167 at UBS
8d ago
Sarepta reports Q1 EPS 73c, consensus (7c)
PremiumThe Fly
Sarepta reports Q1 EPS 73c, consensus (7c)
9d ago
Biotech Sector: M&A Fuels Renewed Excitement
PremiumMarket News
Biotech Sector: M&A Fuels Renewed Excitement
10d ago
PepGen price target lowered to $20 from $21 at Wedbush
PremiumThe Fly
PepGen price target lowered to $20 from $21 at Wedbush
2M ago
Sarepta price target raised to $167 from $164 at UBS
PremiumThe Fly
Sarepta price target raised to $167 from $164 at UBS
2M ago
Sarepta price target raised to $157 from $151 at RBC Capital
PremiumThe Fly
Sarepta price target raised to $157 from $151 at RBC Capital
2M ago
More SRPT News >

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SRPT’s Media Buzz Sentiment?
Currently, no data Available
What is SRPT’s weekly average amount of articles?
Currently, no data Available
What is SRPT’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
ELVElevance Health
CGEMCullinan Management
MRNSMarinus
EWEdwards Lifesciences
INSPInspire Medical Systems
Showing the stocks with the most bullish news sentiment over the past week
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis